Live
FierceBiotechTakeda’s TYK2 inhibitor beats Bristol Myers’ Sotyktu in phase 3 psoriasis showdownEndpoints NewsTakeda's plaque psoriasis pill beats Bristol Myers' Sotyktu in Phase 3Endpoints NewsNeion Bio raises $23M Series A to make proteins from chicken eggsClinical OMICsApp-Controlled “Wound Zipper” Aids Bespoke Skin HealingEndpoints NewsExclusive: Genentech closes infectious disease unit in wave of research layoffs10x Genomics Blog10x Genomics Acquires Proteintech Genomics To Expand Proteomics Capabilities - Pulse 2.0IlluminaIllumina upgraded to overweight at JPMorgan on clinical demand outlook - Investing.comEndpoints NewsRare disease biotech Beren adds $300M from new financingsClinical OMICsAI Tool Classifies 102 CNS Tumor Subtypes in MinutesClinical OMICsFast-Acting Malaria Drug Shows Promise in First-in-Human StudyClinical OMICsUltrasensitive HPV DNA Blood Test Could Help Personalize Head and Neck Cancer TreatmentClinical OMICsDigital Portal Strengthens Patient Engagement in Cancer Clinical Trials
Body unavailable. Use the original source.